The Claim
In human retinal pigment epithelial cells (ARPE-19), exposure to a lutein-zeaxanthin-curcuminoid formulation (iXAN™) at concentrations up to 1000 µg/mL results in cell viability above 93%, indicating low cytotoxicity and a wide safety margin for retinal exposure.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
When human retinal cells are exposed to a supplement containing lutein, zeaxanthin, and curcuminoids at concentrations up to 1000 µg/mL, more than 93% of the cells remain alive, showing that the substance is not toxic to these cells at this dose.
See the scientific wording
In human retinal pigment epithelial cells (ARPE-19), a lutein-zeaxanthin-curcuminoid formulation (iXAN™) at concentrations up to 1000 µg/mL maintains cell viability above 93%, indicating low cytotoxicity and a wide safety margin for retinal exposure.
Lutein, zeaxanthin, and curcuminoids enter retinal cells and block harmful light and free radicals, while also turning on the cell's own defense systems to clean up damage and protect energy factories, keeping the cells alive even under intense stress.
What the research says
1 studyIn lab-grown human eye cells, the supplement iXAN™ didn’t kill any cells—even at very high doses—so it’s likely safe for the eye. The study directly tested this and found over 93% of cells stayed alive.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.